Trial Profile
Phase II trial of gevokizumab in patients with acute gout.
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2012
Price :
$35
*
At a glance
- Drugs Gevokizumab (Primary)
- Indications Gout
- Focus Therapeutic Use
- Sponsors XOMA
- 31 Dec 2008 Status changed from planning to suspended
- 06 Jun 2008 New trial record.